Inhibition of type I interferon signalling prevents TLR ligand-mediated proteinuria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of type I interferon signalling prevents TLR ligand-mediated proteinuria

Published:2013-09-10 Issue:2 Volume:231 Page:248-256
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Gurkan Sevgi¹,Cabinian Allison¹,Lopez Victoria¹,Bhaumik Mantu¹,Chang Jer-Ming²,Rabson Arnold B¹,Mundel Peter³

Affiliation:

1. Child Health Institute of New Jersey, Department of Pediatrics; Rutgers, The State University of New Jersey; New Brunswick NJ USA

2. Department of Internal Medicine; Kaohsiung Medical University; 80756 Taiwan

3. Harvard Medical School and Division of Nephrology; Massachusetts General Hospital; Boston MA 02129 USA

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.4235/fullpdf

Reference46 articles.

1. Deciphering the complexity of Toll-like receptor signaling;Ostuni;Cell Mol Life Sci,2010

2. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways;Hoebe;Nature Immunol,2003

3. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins;Darnell;Science,1994

4. Tracking interferon in autoimmunity;Pascual;Immunity,2012

5. Cell biology and pathology of podocytes;Greka;Annu Rev Physiol,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis;2024-01-16

2. Repurposing drugs for diseases associated with podocyte dysfunction;Kidney International;2023-09

3. Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia;World Journal of Diabetes;2022-12-15

4. The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences;Pharmaceutics;2022-09-08

5. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy;Frontiers in Immunology;2022-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3